Ornithine decarboxylase (ODC) was discovered in animal tissues in 1968 [1, 2] and interest in its activity and regulation has led to a rapidly and still expanding literature on the enzyme. Several comprehensive reviews have already appeared [3] [4] [5] [6] . This article emphasizes our current knowledge of ODC in mammalian skin. The involvement of ODC in tumor promotion will be discussed only briefly, since several rece nt monographs review this subject [7] . The extensive literature on ODC in tissue culture systems will be omitted for the sake of brevity.
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Ornithine decarboxylase is the first enzyme in the biosynthetic pathway for the polyamines, putrescine, spermidine and spermine ( Fig. 1) . Putrescine is the immediate product of ODC; and spermidine and spermine are synthesized from putrescine by the addition of aminopropyl groups generated by the enzyme S-adenosyl-Lmethionine decarboxylase. The polyamines spermidine and spermine are polycationic molecules which interact strongly with nucleic acids. Polyamines stabilize the structure of both DNA and RNA and also participate in many enzymatic reactions involving nucleic acids, such as transfer RNA aminoacylation, protein synthesis and RNA transcription [4, 5] . Intracellular levels of polyamines and their biosynthetic enzymes are generally found to correlate with growth, though a cause and effect relationship has not been proven. Since ODC is the ratelimiting enzyme for polyamine synthesis, its control has been of prima ry interest a nd importance in most studies. BIOCHEMISTRY L-ornithine is sy nthesized in skin fro m arginine by the enzyme arginase. D eterminations in the rat, guinea pig and man s how that it represents 0.25 to 6.42 mole % of the free amino acids in skin [8] . ODC is a cytosol enzy me that enzymaticall y removes C0 2 at the 1 position ofL-ornithine to yield putrescine. P utrescine and C0 2 are formed with a 1:1 sto ichiometry [1, 9] . ODC activity is generally assayed by measuring the release of 14 C O~ from [1-1 "C]-ornithine. The enzy me does not require metal ions and has an optimum pH of 7.0-7.3 depending on the buffer. The K"' for L-ornithine varies from 0.026-0.19 mM , d epending on the sou1·ce and pw·ity of the e nzyme (1, 10, 11] . ODC activity is inhibited by its product, putrescine, and by a variety of product and substrate analogues including spermidine
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Abbreviations: MIX: 1-methyl-3-isob utylxanth ine ODC: ornith ine decarboxylase TPA: 12-0-tetradecanoyl phorbol-13-acetate 207 and spermine. Low concentrations of pu trescine (2 J.LM) result in competitive inhibition [1], but at higher concentrations (10 mM) inhibition becomes noncompetitive (11] . Pyridoxal phosphate is required for enzymatic activity, with an apparent Km ofO.l mM [11] . Inhibitors of pyridoxal-requiring enzymes (e.g. isonicotinic acid hydrazide and 4-bromo-3-hydroxy benzloxamine) inhibi t mam malian ODC activity [1). Binding of the L-ornithine substrate to th e active site takes place tlu-ough Schiff base formation with enzyme-bound pyridoxal phosphate. The irreversible inhibition of ODC activity seen with cer tain substrate analogues requires Schiff base complexing of the inhibitor with pyridoxal phosphate in t he enzy me's active site [12) . The noncompetitive inhibition of ODC activity seen at high concentrations of putrescine or its analogues appears to result from competition for pyridoxyl phosphate by the enzyme and t he polya mine.
Dithiothreitol, at a concentration of 5 mM , is also required for optima] ODC enzymatic activi ty. Monothiol red ucing agents, including reduced glutathione, a major reducing agent in s kin, ar e considerably less effective. In the absence of added thiols, ODC apperu·s to undergo poly merization to lar ger, often inactive forms [10) . When isolated and chmmatographed in the presence ofO.l mM pyridoxal phosphate a nd 5.0 mM dithiotlu-eitol, ODC from rat skin elutes fro m a calibrated Biogel-P!OO column with an estimated molecu lar weight of 52,000 (J. Lesiewicz a nd L.A. Goldsmith, unpublished observations) .
ODC IN NORMAL SKIN
The activity of orn ithine decarboxylase is generally high in rapidly proliferating cells. Fetal tissues and organs possess high ODC activity, which then decreases postnatally [4] . No data is yet available on OD C levels in fetal periderm, epidermis or whole skin. ODC activity is ge nerally reported as specific activity per mg protein and has not been correlated with cell numbers or the number of cells in pruticular cell layers. St4dies in rat dorsal whole skin indicate that basal ODC activity decreases p1~ogressively as the anin1als grow from pre-weanling to yo ung adul t [9) . Pre-weanling mice aTe found to exhibit a tran ient increase in skin ODC in r esponse to subcutaneous injection of epidermal growt h factor [13) .
Basal ODC activity (per mg soluble protein ) is higher in th e dermis t han in the epidermis [9] ; presumably most of t he dermal ODC is follicular in origin . In hair follicl es, ODC activity correlates positively with the cyclic growth of hair, wi th minimal activity found during t he r esting phase [14] . Both folliculru· and interfolliculru· epidermal ODC activities are stimul ated by plucking of telogen h airs. ODC activity decreases initia lly, then rises to peak levels 4 hr after hair plucki ng. A high level of activity is maintained for at least 12 ru· after plucking [9, 14, 15] .
As reported for other mammalian organs, ODC from sk in has a unusuall y short biological half-life. In unstin1Uiated whole dorsal rat skin extracts, ODC exhibits a half-life of 29. tiona! alterations h as been studied. When rats are fed diets containing from 2 to 24% protein for 4 or 8 days, the level of ODC activity in both unstimulated a nd plucked skin is found to increase with increasing dietary protein. Rehabilitation with 16% protein diet after 7 days of a 2% protein diet indicates that ODC enzyme activity increases over 5 days to levels near or slightly higher th an controll6% protein diet levels [9] . Further experiments have determined th at both unstimulated a nd plucked skin ODC activity levels are maintained for up to 24 hr of starvation, followed by significant decreases below fed controls. Under th ese condi tions the half-life of unstimulated ODC is red uced to 1-3.2 min . Following 24 hr of starva tion, refeeding of complete diet for 12· or 24 hr restores ODC enzy me activity to fed control levels (J. Chain, J . Lesiewicz a nd L.A. Goldsmith, unpublish ed observations) . Refeeding of protein deficient diets for up to 24 hr does not restore unstimulated or stimulated ODC activity to control levels, and stimulated ODC activity appears to correlate with dietary protein levels (J . Lesiewicz, D. Morrison and L. A. Goldsmith, _ unpublish ed observations). Skin ODC activity is stimulated by wounding. In rat whole skin wounded by punch biopsy,' ODC activity levels rise rapidly to a maximum 12 hr later. Enzyme activity returns to basal levels by 48 h.r [16] . Similar .results are seen in mouse epidermis wound ed by eith er multiple cuts ·or abrasion. Maximal ODC activity is detected 20-26 hr after wounding and a secondary rise occurs at 72 lu [17] . Administration of th e synthetic glucocorticoid, betamethasone, delays the rise in ODC activity in wounded skip [16] . The delay of wound healing produced by topical treatment of skin with the drug Furacin, may result from inhibition of ODC induction [18] .
ODC IN HYPERPLASIA AND DISEASE
Irradiation of hairless mice with ultraviolet light of wavelengths 290 to 320 nm (UVB) produces thickening of the epidermis within 48 hr. ODC activity in UVB-in:adiated epidermis begins to incr ease within 2 hr after irradiation and reaches a peak 250 to 350-fold greater than unirradiated controls after 28 hr. Enzyme activity declines to near control levels after 48 hr. The increase in ODC activity resulting from UVB exposure is dose dependent and is inhibited by both cycloheximide ami 5-azacytidine, indicating a requirement for de novo protein and RNA synthesis [19] . The anti-inflammatory glucocorticoids triamcinolone acetonide, and fluo cinolone acetonide and the prostagla ndin cyclooxygenase inhibitor, indomethacin, are effective inhibitors of UVB induction of ODC activity in mouse [20] . Irradiation of skin with longwave ultraviolet light (UV A) is known to potentiate UVB-induced erythema in humans a nd rabbits. Photoaugmentation of epid ermal ODC activity by UV A irradiation eit her before or after UVB treatment does not appear to occur [21] .
A major clinical characteristic of psoriasis is increased epidermal proliferation in both involved and uninvolved skin as compared to normal. Polyamine levels in psoriatic epidermis have been reported to be decreased as compa red to normal skin bas· ed on nmoles of spermidine or spermine per gram tissue [22] . More recent determinations have shown putresc ine, spermidine and spermine levels to be increased in involved vs. uninvolved and uninvolved vs. normal skin [23] . This data is expressed as nmoles per J.Lg DNA, which should more accm·ately reflect cell numbers in the tissue samples. The ODC activity of involved psoriatic skin is significantly higher than that found in uninvolved or normal skin . Uninvolved skin has a somewhat higher ODC activity than normal skin . Treatment of psoriatic lesions with the glucocort icoid, diflorason e diacetate, reduced the activity of ODC by 81% [23] .
The effects of UV A and psora! en have been studied in a model system. In the hairless mouse, UV A alone or topical treatment with 8-methoxypsoralen (8-MOP ) plus UV A at 0.9 J /cm 2 , does not increase epidermal ODC activity. However, 8-MOP plus UVA at 3.6 J /cm 2 r esults in a 4-fold increase in ODC activity 16 to 72 hT posttreatment. Similar treatment using anthracene plus UV A at 3. 1 J /cm 2 also induces ODC, bu t maximal enzyme activity is seen at 4 hr and declines to control levels by 48 hT [24] .
In skin tumors ODC and S-adenosylmethionine decarboxylase activities are increased; sq uamous cell car cinomas have higher levels than basal cell carcinomas [25] . High levels of ODC activity are also induced in mouse epidermis by application of tumor promoteTs, such as croton oil or its active component 12-0-tetradeca noyl phorbol-13-acetate (TPA) . A single topical application of TPA results in a several hundred fold increase in ODC activity 4 to 5 hr later. The degree of stinlUlation of ODC is generally found to correlate closely with the promotional ability of various phorbol esters when compared on an equimola1· basis [26] . This correlation has led to the proposal that the induction of ornithine decarboxylase may be an obligatory event in skin carcinoge nesis [27] . Experiments with TPA and vitamin A analogs h ave also determined that the order of retinoid potency for the inhibition of skin tumor promotion, or for suppression of ODC induction is identical [28, 29] .
More recent evidence has indicated that the relationship of ODC induction to tumor promotion is no t as clear -cut as is suggested above. Mezerein, an antileukemic agent with structural similarities to TPA, induces epidermal ODC activity to the same extent and with the same time course as TP A. However, mezerein is a very weak tumor promoter with 2% or less the potency of TP A [30] . When weak or non promoting phorbol esters are a pplied to mouse epidermis in doses which stimulate 3 H-thymidine labeling of DNA equally with TPA, comparable inductions of ODC enzyme activity are also seen [31] . This suggests that the indu ction of ODC may more accurately reflect the degree of epidermal hyperplasia rather than tumor promotion per se. TP A has also been observed to stimulate ODC activity in rat epidermis, a tissue for which it is no t known to be a tumor promoter [15] .
Similarities between TPA-treated epidermis and psoriatic epidermis led to investigation of th e effects of t he anti-psoriatic drug anthralin in this system. Anthralin alone is a weak tumor promoter a nd stimulator of ODC activity [26] . Treatment of mouse skin with anthralin prior to TPA however, results in substantial inhibition of both tumor formation and ODC induction [32, 33] . Information on the effects of the clinically used
REGULATION OF ODC
A number of mecha nisms for the regulation of ODC have been proposed. Most of the research in this area has bee n done in organs other than skin, a nd will only be briefly discussed.
In vivo administration of polyamines at t he time of partial hepatectomy, blocks the induction of ODC during live r regeneration in the rat [3] [4] [5] . These data suggest regul ation of ODC activity at the level of gene transcription . Administra tion of diamine inhibitors subsequent to the induction of ODC in regenerating liver a lso r esul ts in substantial inhibition of ODC activity. This inhibition of ODC is associated with a decrease in the amount of immuno-reactive enzyme protein, and the authors propose a direct inhibition of enzym e synthesis [34] . Other eviden ce indicates that prolonged treatment of liver with the putrescine a nalog, 1,3-diaminopro pane, leads to the formation of a nondialyzeable, macromolecular inhibitor (antizyme) of ODC in liver [34, 35] .
Possible involvement of cycl ic nucleotides in the regulation of ODC has also been investigated. Alterations in the levels of cyclic AMP (cAMP) , cAMP-dependent protein kinase and ODC have been found to occur in a close temporal sequence in regenerating rat liver [36] . Direct evidence of phosphorylation or d ephosphorylation of ODC enzyme has not been reported. Administration of dibu tyryl cAMP or th e potent phosphodiesterase inhibitor, 1-methyl-3-iso butylxanthine (MIX) does result in a n increase in hepatic ODC. This increase can be abolished, however , by prior hypophysectomy. No increase in OPC activity is detected in livers perfused with dibutyryl cAMP or MIX [ 37] . These data indicate that the apparent induction of ODC by cAMP is mediated through pituitary and/or adrenal hormones in the intact animal.
The isolation of multiple, active and inactive forms of ODC fro m various tissues has raised the possibility of their participation in the regulation of enzy me activity. However , this research has all been conducted with ODC enzyme prepa1·ed in buffers containing no, inappropriate, or su boptimal concentration s of th iols. The appearance of multiple form s of the enzyme may then be an artifact of such conditions (see "Biochemistry" section) .
The relatively short biological half-life of ODC allows this enzym e to ra pidly reflect changes in rates of protein synthesis and degradation. Alterations of th e half-life of ODC have been reported under several conditions of stimulation or inhibition (references 3,5,34, see "Normal Skin" section) . However, lit tle or no research has been directed toward elucidating the mechanisms by which ODC is degraded. The group-specific proteases for pyridoxal-requiring enzymes may be involved. These proteases catalyze limited proteolysis of the a po form of pyridoxal enzymes. It has been proposed that their function involves inactivation and initia tion of degradation of most, bu t possibly not all, pyridoxal enzy mes [38] . Modulation of such a protease could specifically alter ODC activity levels in the absence of effects on total cellular protein. Pro teases for pyridoxal enzymes have been reported in several types of endothelial tissue [38] and are likely to be present in s kin.
Several studies have now indicated that ODC induction by diffe rent agents may occur via different mechanisms. Poso, Guha a nd J a nne [39] found that the half-life of liver ODC is lengthened in thioacetamide-or carbon tetrachloride-treated rats, but not in growth hormone-treated animals. Canellakis and Theoharides [40] reported that the indu ction of ODC in cultured rat hepatoma cells by dibutyryl cyclic AMP or dexameth asone differed in time course, inhibition by polyamines and inhibition by Actinomycin D. Our own studies on th e respo nse of rat s kin ODC to either ha ir plucking or TP A has also revealed differences in time course a nd sensitivity to inhi-ORNITHINE DECARBOXYLASE IN SKIN 209 bition by either Actinomycin D or indometh acin [15] . These data strongly s upport the conclusion that different inducers may affect different aspects of the control of ODC activity.
SUMMARY, SPECULATIONS AND PROSPECTIVES FOR FUTURE RESEARCH
Ornithine decarboxylase a nd the polyamines are central to normal a nd abnormal growth. The basic characteristics of th e biochemistry of ODC seem similar in skin and other tissuesspecial advantages of skin have not yet been exploited, and i.e. ODC and the polyamines have not been localized to particular cell layers or portions of the cell. The cellular localization and compar tmentalization of th e polyamines and th eir transport between the ceJJ membrane, cytoplasm a nd nucleus are no doubt important and h ave not been studied in any t issues. Diseases have not been studied extensively; studies of diseases will have to be controlled for disease type a nd should emphasize combined studies of polyamines and ODC. Various stimuli will increase skin ODC, but more than one mechanism h as already been found in skin and studies showing increases in ODC should be interpreted with that caveat. Many studies have emphasized transcriptional control of ODC and the antizyme concept . Studies with enucleated ceJJs produced by cytochalasin B have shown that cytoplasts (cytoplasm freed of nuclei) can respond to stimuli for growth with an increase in ODC [41] . This event in a non-nucleated cell must be controlled at a translational level a nd opens ma ny previous ODC experiments to alternate interpretations. Since the polyamine pathway is influenced at many levels by structural analogues of the substrate or cofactor, modification of the pathway with both topical a nd systemic drugs is to be expected and those results should be of great interest.
We wou ld lik e to t hank those colleagues who so kindly provided us with current abstracts, ma nuscripts in press, and discussions of t hei1· unpublish ed work in progress.
